|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Washington Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing WashingtonLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Aptevo Therapeutics Inc.
| | | Phone: | (206) 838-0500 | Fax: | 206) 838-0503 | Year Established: | 2015 | Ticker: | APVO | Exchange: | NASDAQ | Main Contact: | Marvin L. White, President & CEO | | Other Contacts: | Jane Gross, Ph.D., Senior VP & CSO Mike Adelman, VP, Commercial Operations Shawnte Mitchell, VP, Human Resources & General Counsel Randy J. Maddux, Senior VP, Operations Scott C. Stromatt, M.D., CMO & Senior VP, Clinical Development & Medical Affairs Jeff Lamoth, Senior VP & CFO
| | Company Description | Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. They leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. | |
|
|
|
|
|